-
Adaptilens
Developing the first and only intraocular lens that responds to the eye's natural signal to focus, thus eliminating the need for eyeglasses or contact lenses.
-
Aperture Bio
Realizing orders-of-magnitude improvements in speed and sensitivity, Aperture rapidly analyzes proteins in whole cells to map immune interactions.
-
Aurie
Building a reusable, intermittent catheter system to improve quality of life and health outcomes for people living with urinary retention.
-
Beacon Bio
Improving hearing and healing by restoring eardrums with regenerative grafts.
-
Broadleaf HEA
Providing evidence-based health and education interventions for children in rural India that produce tangible improvements to participant’s wellbeing.
-
Concerto Biosciences
Discovering microbial ensembles for health via a patented screening platform.
-
EndoShunt Medical Inc.
Controlling abdominal bleeding in trauma surgery with an innovative medical device.
-
Limax Biosciences
Treating internal and external injuries with a stretchable adhesive hydrogel.
-
Mark43
Empowering communities and their governments with new technologies that improve the safety and quality of life for all.
-
PerioSense
Making early diagnosis of gum disease more accessible and efficient while saving time and money for patients and providers.
-
PlenOptika
Enabling eye care for all with the QuickSee — a simple, affordable device that prescribes eyeglasses at the push of a button.
-
Stochastic
An enterprise platform for businesses to build, customize, and control their own AI.
-
Stratagen Bio
Transforming MRI scans into a tool for objective clinical decision-making and quantitative biomarker assessment.
-
SurgiBox
Making surgery safer for both patients and healthcare providers around the world through innovative technology, co-developed with users and centered around patient needs.
-
Umbulizer
Developing a reliable, low-cost, and portable device that can provide continuous ventilation to patients.
-
Vacuum-Assisted Wound Therapy Affordable For All (VATARA)
Providing low-cost, negative pressure wound therapy for everyone.
-
X-COR Therapeutics
Creating the first commercially-available extracorporeal CO2 removal device that uses ultra-low-blood flow to treat patients with hypercarbic respiratory failure.
Take On the Challenge
Students: Apply for the PIC by Dec. 05.